Blood Advances

ISSN: 2473-9529
eISSN: 2476-9537
Publisher: American Society of Hematology

Publications (27)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL (2023) Blumenberg V, Busch G, Baumann S, Jitschin R, Iacoboni G, Gallur L, Iraola-Truchuelo J, et al. Journal article Neutrophil transit time and localization within the megakaryocyte define morphologically distinct forms of emperipolesis (2022) Huang FY, Cunin P, Radtke FA, Darbousset R, Grieshaber-Bouyer R, Nigrovic PA Journal article Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans (2022) Brandl A, Solimando AG, Mokhtari Z, Tabares P, Medler J, Manz H, Da Via MC, et al. Journal article Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset. (2022) Böttcher M, Panagiotidis K, Bruns H, Stumpf M, Völkl S, Geyh S, Dietel B, et al. Journal article Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. (2022) Etra A, Gergoudis S, Morales G, Spyrou N, Shah J, Kowalyk S, Ayuk F, et al. Journal article Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model (2021) Hashtchin AR, Fehlhaber B, Hetzel M, Manstein F, Stalp JL, Glage S, Abeln M, et al. Journal article Single- And double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM (2021) Truger MS, Duell J, Zhou X, Heimeshoff L, Ruckdeschel A, John M, Riedel A, et al. Journal article Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article
1 2 3